Trailing-twelve-month (TTM) revenue is $606.91 Million with a year-over-year growth of (8.32%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $139,613,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $172,927,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-19 |
| Q1 FY2026Period ended 2026-03-31 | $142,211,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $152,157,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $606,908,000 |
Current P/S: $3,688,958,183 market capitalization ÷ $606,908,000 TTM revenue = 6.08x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:10:19.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $152.16M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:14:13.588Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Contract Research Services | $14M | $16M | $18M | $16M | $15M | $23M |
| Material Sales | $230M | $319M | $331M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| CHINA | $142M | $192M | $231M | $230M | $229M | $238M |
| JAPAN | $7M | $7M | $6M | $7M |
$606.91M
$606.91 Million
(8.32%)
vs. $661.99M a year ago (TTM)
+3.05%
5 Year compound annual growth rate
1 Year
(8.32%)
3 Year
+0.02%
5 Year
+3.05%
10 Year
+11.98%
15 Year
+20.14%
20 Year
+21.70%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $650.61M | +$2.93M | +0.45% |
| 2024 | $647.68M | +$71.25M | +12.36% |
| 2023 | $576.43M | ($40.19M) | (6.52%) |
| 2022 | $616.62M | +$63.09M | +11.40% |
| 2021 | $553.52M | +$124.66M | +29.07% |
| 2020 |
TTM Growth
(8.32%)
3-Year CAGR
+0.02%
5-Year CAGR
+3.05%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T17:14:13.588Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $365M |
| $353M |
| Royalty And License Fees | $185M | $219M | $267M | $238M | $267M | $275M |
|---|
| $3M |
| KOREA, REPUBLIC OF | $263M | $335M | $361M | $323M | $398M | $384M |
|---|
| Non-US | N/A | N/A | N/A | N/A | N/A | $626M |
|---|
| Other Non U S | $2M | $3M | $4M | $4M | $2M | $2M |
|---|
| UNITED STATES | $15M | $16M | $16M | $13M | $14M | $24M |
|---|
| $428.87M |
| +$23.69M |
| +5.85% |
| 2019 | $405.18M | +$157.76M | +63.76% |
| 2018 | $247.41M | ($88.22M) | (26.28%) |
| 2017 | $335.63M | +$136.74M | +68.75% |
| 2016 | $198.89M | +$7.84M | +4.10% |
